All GLP-1 Medications
FDA-approved GLP-1 and dual GIP/GLP-1 receptor agonist medications currently available in the United States.
Ozempic
semaglutide — Novo Nordisk
14.9%
Weight loss
Once weekly
Frequency
$935-$1,029/month
List price
Type 2 diabetes mellitus (adjunct to diet and exercise)
Wegovy
semaglutide — Novo Nordisk
16.9%
Weight loss
Once weekly
Frequency
$1,349-$1,650/month
List price
Chronic weight management in adults with BMI ≥30 or ≥27 with at least one weight-related comorbidity
Mounjaro
tirzepatide — Eli Lilly
22.5%
Weight loss
Once weekly
Frequency
$1,023-$1,176/month
List price
Type 2 diabetes mellitus (adjunct to diet and exercise)
Zepbound
tirzepatide — Eli Lilly
22.5%
Weight loss
Once weekly
Frequency
$1,060-$1,176/month
List price
Chronic weight management in adults with BMI ≥30 or ≥27 with at least one weight-related comorbidity (adjunct to diet and exercise)
Rybelsus
semaglutide — Novo Nordisk
4.4%
Weight loss
Once daily
Frequency
$935-$1,029/month
List price
Type 2 diabetes mellitus (adjunct to diet and exercise)
Trulicity
dulaglutide — Eli Lilly
3.1%
Weight loss
Once weekly
Frequency
$950-$1,100/month
List price
Type 2 diabetes mellitus (adjunct to diet and exercise)
Saxenda
liraglutide — Novo Nordisk
8%
Weight loss
Once daily
Frequency
$1,349/month
List price
Chronic weight management in adults with BMI ≥30 or ≥27 with at least one weight-related comorbidity
Victoza
liraglutide — Novo Nordisk
3.2%
Weight loss
Once daily
Frequency
$950-$1,100/month
List price
Type 2 diabetes mellitus (adjunct to diet and exercise)
Byetta
exenatide — AstraZeneca
2.8%
Weight loss
Twice daily (within 60 min before meals)
Frequency
$800-$900/month
List price
Type 2 diabetes mellitus (adjunct to diet and exercise)
Bydureon BCise
exenatide extended-release — AstraZeneca
2.3%
Weight loss
Once weekly
Frequency
$800-$950/month
List price
Type 2 diabetes mellitus (adjunct to diet and exercise)